Cognitive and Fusion Prostatic Biopsy
Recruiting · NCT07306741 · Interventional (participants receive a specific treatment) · Lead sponsor: Menoufia University
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The goal of this study is to compare two different prostate biopsy techniques used to detect prostate cancer. These techniques are cognitive-targeted biopsy (CTB) and magnetic resonance imaging-ultrasound fusion-targeted transrectal biopsy (FTB). Both methods aim to improve the accuracy of prostate cancer detection by targeting suspicious areas identified on prostate imaging. This study will compare how accurately each technique detects prostate cancer, the pathological findings obtained from each biopsy method, and how operator performance may influence the procedure. The information gained from this study may help improve prostate cancer diagnosis and guide future biopsy practices.
Who can take part
Inclusion criteria
- Biopsy-naïve patients
- Prostate-specific antigen level between 4 and 20 ng/mL
- Multiparametric Magnetic Resonance Imaging Prostate Imaging-Reporting and Data System score 4 or 5
Exclusion criteria
- Prior prostate biopsy
- Prostate-specific Antigen level outside the specified range
- Contraindication to Magnetic Resonance Imaging
Where it is running
2 locations listed.
- Menoufia university hospital urology department - Shibīn al Kawm, Egypt
- Menoufia university hospital urology department - Shibīn al Kawm, Egypt